CROSS RESISTANCE AND COLLATERAL SENSITIVITY STUDIES IN CANCER CHEMOTHERAPY.
D000477:Alkylating Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D001377:Azaserine; D003078:Colchicine; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D005493:Folic Acid Antagonists; D006146:Guanidines; D006801:Humans; D007930:Leucine; D008660:Metabolism; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental; D010600:Pharmacology; D011687:Purines; D011743:Pyrimidines; D013256:Steroids; D046509:Tissue Culture Techniques
D000477:Alkylating Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D006146:Guanidines; D011687:Purines; D011743:Pyrimidines; D013256:Steroids; D001377:Azaserine; D007930:Leucine; D003078:Colchicine; C030985:purine
ALKYLATING AGENTS; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS; AZASERINE; COLCHICINE; DRUG RESISTANCE, MICROBIAL; FOLIC ACID ANTAGONISTS; GUANIDINES; LEUCINE; METABOLISM; NEOPLASM THERAPY; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; PURINES; PYRIMIDINES; REVIEW; STEROIDS; TISSUE CULTURE